KDventures AB (FRA:2I9)

Market Cap	18.25M -17.3%
Revenue (ttm)	154.41K -9.1%
Net Income	-17.91M
EPS	-0.07
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	57
Open	0.0017
Previous Close	0.0001
Day's Range	0.0017 - 0.0017
52-Week Range	0.0001 - 0.0847
Beta	n/a
RSI	49.16
Earnings Date	Apr 30, 2026

About KDventures AB

KDventures AB is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2003
• Employees: 7
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2I9

Financial Performance

In 2025, KDventures AB's revenue was 1.67 million, a decrease of -9.09% compared to the previous year's 1.84 million. Losses were -193.86 million, 2293.0% more than in 2024.

Financial numbers in SEK